BlackRock’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-564,004
| Closed | -$1.88M | – | 5045 |
|
|
2019
Q4 | $1.88M | Sell |
564,004
-33,348
| -6% | -$111K | ﹤0.01% | 3755 |
|
|
2019
Q3 | $1.82M | Buy |
597,352
+52,456
| +10% | +$159K | ﹤0.01% | 3735 |
|
|
2019
Q2 | $1.3M | Sell |
544,896
-41,165
| -7% | -$97.9K | ﹤0.01% | 3877 |
|
|
2019
Q1 | $2.2M | Sell |
586,061
-34,755
| -6% | -$130K | ﹤0.01% | 3631 |
|
|
2018
Q4 | $2.23M | Buy |
620,816
+142,159
| +30% | +$510K | ﹤0.01% | 3600 |
|
|
2018
Q3 | $2.74M | Buy |
478,657
+6,821
| +1% | +$39.1K | ﹤0.01% | 3615 |
|
|
2018
Q2 | $2.36M | Buy |
471,836
+6,030
| +1% | +$30.2K | ﹤0.01% | 3632 |
|
|
2018
Q1 | $2.39M | Sell |
465,806
-43,558
| -9% | -$223K | ﹤0.01% | 3594 |
|
|
2017
Q4 | $3.06M | Sell |
509,364
-61,416
| -11% | -$369K | ﹤0.01% | 3531 |
|
|
2017
Q3 | $3.17M | Buy |
570,780
+35,377
| +7% | +$196K | ﹤0.01% | 3536 |
|
|
2017
Q2 | $2.48M | Buy |
535,403
+19,258
| +4% | +$89.3K | ﹤0.01% | 3584 |
|
|
2017
Q1 | $2.56M | Buy |
+516,145
| New | +$2.56M | ﹤0.01% | 3549 |
|
|
2016
Q2 | – | Sell |
-1,567
| Closed | -$10K | – | 3799 |
|
|
2016
Q1 | $10K | Buy |
1,567
+995
| +174% | +$6.35K | ﹤0.01% | 3124 |
|
|
2015
Q4 | $5K | Hold |
572
| – | – | ﹤0.01% | 3148 |
|
|
2015
Q3 | $4K | Hold |
572
| – | – | ﹤0.01% | 3075 |
|
|
2015
Q2 | $6K | Buy |
+572
| New | +$6K | ﹤0.01% | 3050 |
|